🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you to our many #ValveWeek23 community partners, who listened to hearts across Canada 🇨🇦 and helped raise awareness about symptoms of #heartvalvedisease and the importance of a stethoscope check. 🧵1/2

Honoured to have received the @scc_ccs Sex and Gender-Based Analysis Trainee Abstract Award in Clinical Sciences during the #VASC23 congress in Montréal ! Proud to have contributed in some extent to this field of study! A warm thanks to my mentors Labo Dr Clavel and Philippe Pibarot IUCPQ-ULaval

Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials jamanetwork.com/journals/jamac…

Very proud to be this year again in the list of the top 1% highly cited researchers in the field of Clinical Medicine. Special thanks to my fantastic research lab team and students IUCPQ-ULaval and to all my collaborators including Labo Dr Clavel RTHahnMD João Cavalcante Clarivate

In this state-of-the-art review from the #PCRLV 2023 issue, the Authors propose an overview on transcatheter mitral valve replacement (TMVR) for the treatment of native mitral valve disease, from indication to results, with a glimpse into the future. eurointervention.pcronline.com/article/transc…

Latest work from our lab published in JACC Advances. Outstanding work by Sébastien Hecht, PhD !

This expert review discusses the utilization of TEER in inoperable and high-risk patients beyond recognized indications, examining outcomes and limitations in diverse populations who are not normally included in major trials (e.g., post-myocardial infarction mitral regurgitation,

Tomorrow, Feb 22nd is ValveDiseaseDay and we are proud to partner with Alliance for Aging Research & CCS to raise awareness of #heartvalvedisease which affects over 1 million Canadians. Learn more about what’s happening across Canada at ➡️ HeartValveVoice.ca

Today is Heart Valve Disease Awareness Day. We are organizing 'Listen to your heart' campaigns across Canada including one here in Québec city. Since this morning we have constant line-up of >50 people! Heart Valve Voice CCS IUCPQ-ULaval Fondation IUCPQ heartvalvevoice.ca/en/news/b30gpw…

#ValveDiseaseDay in #Quebec City 🙏 to the wonderful event partners who hosted 200 participants! IUCPQ-ULaval Philippe Pibarot A stethoscope check 🩺can be the first step in the detection of #heartvalvedisease. It’s common, serious, but treatable. Learn more at heartvalvevoice.ca

Proud to present our AR multicenter project at the ACC congress. I’m grateful to my mentors, Nina Ajmone Marsan and J.J.Bax, to my LUMC team Federico Fortuni and to Philippe Pibarot and Jérémy Bernard, PhD and the rest of the centers without whose collaboration this wouldn’t have been possible.

Finally some improvement in current scholarships support for grad students in Canada! Proud to have contributed in a way to this large campaign in the previous years! I salute Support Our Science hard work in getting this done, François-Philippe Champagne (FPC) 🇨🇦 and Canada Gov for these investments.

Cardiac damage staging in aortic stenosis is ready for prime time. Excellent Editorial by Philippe Pibarot. sciencedirect.com/science/articl… Masaaki Nakase Daijiro Tomii Fabien Praz

Future is now!!! First robotic guided mitral TEER with Mitraclip G4 at Xiamen Cardiovascular Hospital!! Abbott Rodrigo Estévez Philipp Lurz Dr. Gilbert Tang francesco maisano Azeem Latib Paolo Denti Univ.-Prof. Dr. Ralph Stephan von Bardeleben Paul RTHahnMD Fabien Praz Nicole Karam, MD, PhD, FESC Nicolo Piazza

2Yr TRILUMINATE shows ⬇️ in annualized HFH at 24 months in Device group (p=0.02) despite crossovers! bit.ly/2YrTRILUMINATE #ACC25 Circulation American College of Cardiology European Society of Cardiology Ritu Thamman MD

🚨Our last publication. Emerging biomarker, Human Epididymis Protein 4 in Transcatheter Aortic Valve Implantation: Diagnostic and Prognostic Value | JACC: Advances jacc.org/doi/10.1016/j.… Great job!

Félicitations à Philippe Pibarot qui reçoit le Prix Fondation - Carrière en recherche - Pour ses avancées majeures en recherche sur les maladies valvulaires cardiaques et ses innovations technologiques.